ClinicalTrials.govpublic full text
Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma
multiple myeloma, cc-5013, revlimid, mm, cc5013, relapsed and refractory multiple myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 839149
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.